Free Trial

Mineralys Therapeutics (MLYS) SEC Filings & 10K Form

$12.20
-0.03 (-0.25%)
(As of 05/24/2024 ET)

Recent Mineralys Therapeutics SEC Filings

DateFilerForm TypeView
05/22/2024
3:38 PM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:43 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:14 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:07 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:10 AM
Mineralys Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2024
3:24 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
11:15 PM
Mineralys Therapeutics (Filer)
Form EFFECT
04/11/2024
3:35 PM
Mineralys Therapeutics (Filer)
Form 424B5
04/09/2024
6:15 AM
Mineralys Therapeutics (Filer)
Form DEF 14A
04/09/2024
6:18 AM
Mineralys Therapeutics (Filer)
Form DEFA14A
04/09/2024
6:21 AM
Mineralys Therapeutics (Filer)
Form ARS
04/04/2024
7:04 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:44 PM
Mineralys Therapeutics (Filer)
Form S-3/A
03/21/2024
6:43 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
6:30 AM
Mineralys Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/21/2024
6:14 AM
Mineralys Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
4:35 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:20 PM
Mineralys Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
02/14/2024
8:06 PM
Mineralys Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:07 PM
AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:49 PM
Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
5:04 AM
ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
Form SC 13G
02/08/2024
3:41 PM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:01 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
8:04 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
5:18 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
7:20 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
4:15 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
9:06 AM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:11 PM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:13 PM
Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2023
3:13 PM
Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:13 PM
Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:14 PM
Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/08/2023
7:49 AM
Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
6:11 PM
Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
6:11 PM
Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
3:55 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
5:51 PM
Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2023
3:03 PM
Mineralys Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
7:55 AM
Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
07/14/2023
7:55 AM
Mineralys Therapeutics (Issuer)
Takahashi Takeshi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MLYS) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners